How I manage neonatal thrombocytopenia

Area of Science:

• Neonatology
• Hematology
• Pediatric Critical Care

Background:

• Neonatal thrombocytopenia (platelet count < 150×10(9) /l) is a frequent clinical finding.
• Early-onset (<72h) in preterm neonates often resolves spontaneously, while late-onset (>72h) suggests infection or necrotizing enterocolitis.
• Neonatal alloimmune thrombocytopenia (NAIT) is a significant cause in term infants, risking intracranial hemorrhage.

Purpose of the Study:

• To review the diagnosis and management of neonatal thrombocytopenia.
• To highlight the challenges in current treatment strategies, particularly platelet transfusions.
• To emphasize the need for evidence-based transfusion guidelines and further research.

Main Methods:

• Review of clinical history and blood film examination for diagnosis.
• Distinguishing between early- and late-onset thrombocytopenia in preterm neonates.
• Identifying NAIT as a critical diagnosis in term neonates.

Main Results:

• Clinical assessment suffices for many cases of neonatal thrombocytopenia.
• Late-onset thrombocytopenia in preterm infants is frequently linked to severe bacterial infection or necrotizing enterocolitis.
• NAIT requires prompt diagnosis and compatible platelet transfusion to prevent severe complications.

Conclusions:

• Effective management of neonatal thrombocytopenia relies on accurate diagnosis and understanding of underlying causes.
• Current platelet transfusion practices for severe neonatal thrombocytopenia lack robust evidence.
• Controlled trials are essential to establish safe and effective platelet transfusion strategies.